Pharmaceutical innovation and generic challenge: Recent trends and causal factors

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 4, Issue 2, 2010, Pages 175-190

  Dubey, Jayashree ^a   Dubey, Rajesh ^b  

^a Osmania University Campus   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Competitors; Innovation; Pharmaceuticals industry; Product differentiation; Research and development

Indexed keywords

EID: 77954239567     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506121011059777     Document Type: Article

References (5)

1. Aitken, M., Berndt, E.R. and Cutler, D.M. (2009), Prescription drug spending trends in the United States: looking beyond the turning point in Health Affairs, Vol. 28, No. 1, pp. w151-60.
2. Fischer, M.J. (1999), No let up in prescription drug cost rises seen in National Underwriter Life and Health, Vol. 29, p. 4.
3. Grabowski, H. (2004), Are the economics of pharmaceutical research and development changing? productivity, patents and political pressures in Pharmacoeconomics, Vol. 22, Suppl. 2, pp. 15-24.
4. Kvesic, D.Z. (2008), Product lifecycle management: marketing strategies for the pharmaceutical industry in Journal of Medical Marketing, Vol. 8, No. 4, pp. 293-301.
5. Managed Care Outlook (1999), No relief in sight for skyrocketing prescription drug costs in Managed Care Outlook, Vol. 12, No. 39, p. 3.